AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention - Results of the GOLD (AU-Assessing Ultegra) multicenter study
Authors: Steinhubl, SR Talley, JD Braden, GA Tcheng, JE Casterella, PJ Moliterno, DJ Navetta, FI Berger, PB Popma, JJ Dangas, G Gallo, R Sane, DC Saucedo, JF Jia, G Lincoff, AM Theroux, P Holmes, DR Teirstein, PS Kereiakes, DJ
Citation: Sr. Steinhubl et al., Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention - Results of the GOLD (AU-Assessing Ultegra) multicenter study, CIRCULATION, 103(21), 2001, pp. 2572-2578
Clinical pharmacology of higher dose eptifibatide in percutaneous coronaryintervention (the PRIDE study)
Authors: Tcheng, JE Talley, JD O'Shea, JC Gilchrist, IC Kleiman, NS Grines, CL Davidson, CJ Lincoff, AM Califf, RM Jennings, LK Kitt, MM Lorenz, TJ
Citation: Je. Tcheng et al., Clinical pharmacology of higher dose eptifibatide in percutaneous coronaryintervention (the PRIDE study), AM J CARD, 88(10), 2001, pp. 1097-1102
Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trial
Authors: Zhang, Z Mahoney, EM Gershony, G Ellis, S Saucedo, JF Talley, JD Feldman, T Weintraub, WS
Citation: Z. Zhang et al., Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trial, AM HEART J, 142(6), 2001, pp. 982-988
Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry
Authors: Webb, JG Sanborn, TA Sleeper, LA Carere, RG Buller, CE Slater, JN Baran, KW Koller, PT Talley, JD Porway, M Hochman, JS
Citation: Jg. Webb et al., Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry, AM HEART J, 141(6), 2001, pp. 964-970
Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonistdoes not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction
Authors: Kleiman, NS Tracy, RP Talley, JD Sigmon, K Joseph, D Topol, EJ Califf, RM Kitt, M Ohman, EM
Citation: Ns. Kleiman et al., Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonistdoes not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction, J THROMB TH, 9(1), 2000, pp. 5-12
Pharmacology of GP IIb-IIIa platelet inhibitors, part IV
Authors: Talley, JD
Citation: Jd. Talley, Pharmacology of GP IIb-IIIa platelet inhibitors, part IV, J INTERV CA, 13(4), 2000, pp. 243-254
Perforation of the aorta after coronary angioplasty: Coincidental or complication?
Authors: Rayford, R Antakli, T Talley, JD
Citation: R. Rayford et al., Perforation of the aorta after coronary angioplasty: Coincidental or complication?, J INTERV CA, 13(3), 2000, pp. 205-208
Stenting of an anomalous left circumflex coronary artery
Authors: Kelley, S Steely, D Talley, JD
Citation: S. Kelley et al., Stenting of an anomalous left circumflex coronary artery, J INTERV CA, 13(3), 2000, pp. 219-220
It fits! (Intelligence transfer: From images to solutions) massive abdominal ecchymosis and hematoma due to local injection of enoxaparin
Authors: Razek, HA St Pierre, M Talley, JD
Citation: Ha. Razek et al., It fits! (Intelligence transfer: From images to solutions) massive abdominal ecchymosis and hematoma due to local injection of enoxaparin, J INTERV CA, 13(1), 2000, pp. 71-72
Progress in interventional cardiology
Authors: Joseph, J Saucedo, J Talley, JD
Citation: J. Joseph et al., Progress in interventional cardiology, J INTERV CA, 13(1), 2000, pp. 73-76
Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: A report from the SHOCK Trial Registry
Authors: Menon, V Webb, JG Hillis, LD Sleeper, LA Abboud, R Dzavik, V Slater, JN Forman, R Monrad, ES Talley, JD Hochman, JS
Citation: V. Menon et al., Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: A report from the SHOCK Trial Registry, J AM COL C, 36(3), 2000, pp. 1110-1116
Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial
Authors: Tcheng, JE O'Shea, JC Cohen, EA Pacchiana, CM Kitt, MM Lorenz, TJ Greenberg, S Strony, J Califf, RM Buller, C Cantor, WJ Joseph, DM Kitt, MM Lincoff, AM Madan, M Popma, J Teirstein, P Cohen, E Balleza, L Parsons, P Lui, H Young, J Fox, R Labinaz, M Jelley, J Williams, J Cohen, D Trovato, M Smith, J Henry, P Chisholm, R O'Donnell, D Talley, JD Pacheco, R Timmis, S Muraka, A Mann, T Cubeddu, G Tannenbaum, M Greene, J Santoian, E Wash, M Sheldon, S Pronesti, L Jain, A Alonzo, M Seidelin, P Richards, J Lopez, M Dittenber, R Johnson, K Levine, G Maresh, K Ferrando, T Sarembock, I Snyder, L Kieval, J Herlan, L Miller, M Bembridge, D Nair, R Hickel, L Kiernan, F Murphy, D Cloutier, J Conn, E Beardsley, J Ritchie, M Cragen, D Jafar, MZ Counihan, P Rosenfelder, D Ducas, J Montebruno, L Carere, R Radons, B Williams, L Owens, W Dougal, R Feldman, R Audrain, D Karamali, A Smith, M Blankenship, J Demko, SL Thompson, M Gacoich, G Chiodo, V Noll, P Ledley, G Miller, C Felten, W Garner, B Chandler, AB Easler, P Albin, G Page, A Maddox, W Allen, S Gilchrist, I Moore, R Zimmerman, H Curtis, M Hildebrand, K Greene, R Healy, E Meengs, W Carson, D George, J Roncevich, T Aharonian, V Browning, R Kostuk, W Carr, S Feit, F Gostomsky, B Butman, S Hannah, E Hassel, CD Hartley, D Shook, T Hiller-Mullin, S Brill, D Dillion, M Armstrong, B Kerns, D Pichard, A Okubagzi, P Nasser, T Driver, L Garrett, J Boltey, L Stouffer, G Potter, M Amidon, T Eggert, S Taussig, A Potter, K Natarajan, M Tartaglia, C Werner, J Dunlap, T Harrold-Runge, P Davidson, C Goodreau, L Herzog, W Calamunci, N Slater, A Tormey, D Phillips, W White, D Sridhar, K White, J Goodman, D Buchbinder, M Nasser, V Rapeport, K Vorman, P Weiner, B Borbone, M Shadoff, N Paap, C Rehman, A Haag, E Burchenal, J Kioussopoulos, K Senior, D Senior, J Piana, R Kirshenbaum, J Chan, S Chowdry, A Kraft, P Clark, V Fox, M Deutsch, E Shannon, T Quesada, R Brotherton, J Murrin, C Cinderella, J Hearne, S Seefried, V Farah, T Pakstis, D Bartolet, B Bond, C Debarardinis, C Montory, D Smith, G Gray, D Phillips, P Hathaway, S Manoukian, S Patrick, C Yakubov, S Brooks, J Block, P Block, B Muhlestein, JB Kim, S Shalev, Y Schmidt, W Resar, J Citro, K Stine, R Zumbuhl, J Moreyra, A Kreiger, S Berger, P Cannon, CP Fisher, L Hasselblad, V Foster, A Joseph, D Madan, M McLendon, C Rund, M Tillery, N Wood, F Mahaffey, KW Irwin, C Kulick, D Johnson, N Chen, J Greenberg, S Hogeboom, C Lorenz, TJ Terifay, R Strony, J Veltri, E
Citation: Je. Tcheng et al., Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial, LANCET, 356(9247), 2000, pp. 2037-2044
Trial of abciximab with and without low-dose reteplase for acute myocardial infarction
Authors: Topol, EJ Ohman, EM Barnathan, E Califf, RM Lee, KL Lincoff, AM Ohman, EM Scherer, J Scott, R Sketch, MH Topol, EJ Weisman, HF Cantor, W Evans, B Harris, J Kirby, J Miller, J Minshall, D Oliverio, RM Stebbins, AL Webb, L Wittlief, J Topol, EJ Lincoff, AM Moliterno, DJ Ivanc, T Barnathan, E Damaraju, L Hadley, K Kukulewicz, L Scherer, J Scott, R Schwarz, R Waller, M Weisman, H Lincoff, AM Bachinsky, WB Bell, C Butler, JF David, SW Gibbs, K Sakhaii, M Hanovich, G Herrmann, H Hillegass, W Kereiakes, DJ Kiernan, J McGrew, FA Miklin, JS Miller, L Sketch, MH Riba, A Schreiber, TL Smalling, RW Talley, JD Worley, S Bates, ER Hearne, S Morris, DC Priest, MF Pelikan, P Seals, AA Smith, JE Bach, RG Laufer, N Phillips, PS McClure, R Navetta, FI Bhoopalam, V Aylward, PE Ardissino, D Betriu, A della Misericordi, OSM Morocutti, G Muller, DWM Grinfeld, L Cagide, A Bode, C Forycki, F Lefkovits, J Steg, G Macaya, C Schultheiss, HP Eberli, F
Citation: Ej. Topol et al., Trial of abciximab with and without low-dose reteplase for acute myocardial infarction, CIRCULATION, 101(24), 2000, pp. 2788-2794
Relation of coronary artery size to one-year clinical events after new device angioplasty of native coronary arteries - (A New Approach to Coronary Intervention [NACI] Registry report)
Authors: Saucedo, JF Popma, JJ Kennard, ED Talley, JD Lansky, A Leon, MB Baim, DS
Citation: Jf. Saucedo et al., Relation of coronary artery size to one-year clinical events after new device angioplasty of native coronary arteries - (A New Approach to Coronary Intervention [NACI] Registry report), AM J CARD, 85(2), 2000, pp. 166-171
Atorvastatin versus revascularization treatment (AVERT): Fact or fancy?
Authors: Singh, BM Puri, S Saucedo, J Talley, JD
Citation: Bm. Singh et al., Atorvastatin versus revascularization treatment (AVERT): Fact or fancy?, AM HEART J, 140(1), 2000, pp. 6-9
Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: Insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences
Authors: Ellis, SG da Silva, ER Spaulding, CM Nobuyoshi, M Wiener, B Talley, JD
Citation: Sg. Ellis et al., Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: Insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences, AM HEART J, 139(6), 2000, pp. 1046-1053
The changing healthcare market and how it has influenced the treatment of cardiovascular disease - Part 1
Authors: Becker, ER Morris, DC Culler, SD Mauldin, PD Shaw, LJ Talley, JD Weintraub, WS
Citation: Er. Becker et al., The changing healthcare market and how it has influenced the treatment of cardiovascular disease - Part 1, AM J M CARE, 5(9), 1999, pp. 1119-1124
The changing healthcare market: Outlook for the future of cardiovascular disease treatment - Part 2
Authors: Becker, ER Morris, DC Culler, SD Mauldin, PD Shaw, LJ Talley, JD Weintraub, WS
Citation: Er. Becker et al., The changing healthcare market: Outlook for the future of cardiovascular disease treatment - Part 2, AM J M CARE, 5(9), 1999, pp. 1125-1130
Catheter-induced spasm of the left main coronary artery
Authors: McKee, J Saucedo, J Talley, JD
Citation: J. Mckee et al., Catheter-induced spasm of the left main coronary artery, J INTERV CA, 12(4), 1999, pp. 319-320
Progress in interventional cardiology
Authors: Joseph, J Saucedo, J Talley, JD
Citation: J. Joseph et al., Progress in interventional cardiology, J INTERV CA, 12(4), 1999, pp. 321-324
IT FITS! Intelligence transfer: From images to solutions myocardial injurydue to suicidal ingestion of hydrochloric acid
Authors: Hanna, K St Pierre, M Talley, JD
Citation: K. Hanna et al., IT FITS! Intelligence transfer: From images to solutions myocardial injurydue to suicidal ingestion of hydrochloric acid, J INTERV CA, 12(3), 1999, pp. 225-226
Progress in interventional cardiology
Authors: Joseph, J Saucedo, J Talley, JD
Citation: J. Joseph et al., Progress in interventional cardiology, J INTERV CA, 12(3), 1999, pp. 227-230
Interventional management of acute coronary syndromes
Authors: Talley, JD
Citation: Jd. Talley, Interventional management of acute coronary syndromes, J INTERV CA, 12(2), 1999, pp. 117-132
IT FITS! (Intelligence transfer: From images to solutions) - The Holt-Oramsyndrome
Authors: McKee, J Conley, TD Talley, JD
Citation: J. Mckee et al., IT FITS! (Intelligence transfer: From images to solutions) - The Holt-Oramsyndrome, J INTERV CA, 12(2), 1999, pp. 163-163
Medical management of acute coronary syndromes
Authors: Talley, JD
Citation: Jd. Talley, Medical management of acute coronary syndromes, J INTERV CA, 12(1), 1999, pp. 33-49
Risultati: 1-25 | 26-30